Thailand group fights EU-ASEAN FTA

2 March 2009

Thailand's Foundation for Consumers has attacked a proposed free-trade agreement between the European Union and the Association of Southeast  Asian Nations (ASEAN) that would effectively outlaw compulsory licensing  and prohibit the marketing of copy drugs, even without a locally-valid  patent. Jiraporn Limpananont, the Foundation's head, claims that Article  9 of the proposed EU-ASEAN FTA contains sweeping intellectual property  rights protection for R&D drugmakers that go beyond the World Trade  Organization's agreement on Trade-Related Aspects of Intellectual  Property Rights (TRIPs; Marketletters passim).

The Bangkok Post reported that this issue could contribute to public  protests against the ASEAN's trade policy at the regional body's 14th  annual summit in late February. Other elements of the proposed deal  affecting agriculture are also considered controversial.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight